文献速递水电解质与酸碱急性肾损伤

癌症免疫治疗相关的电解质与酸碱紊乱

Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-01-21

本综述聚焦免疫检查点抑制剂与嵌合抗原受体T细胞治疗相关的电解质紊乱。免疫检查点抑制剂可通过多种机制引起低钠血症(以抗利尿不当综合征最常见)、低钾血症(伴近端和远端肾小管酸中毒)、高钙血症(与副肿瘤性甲状旁腺激素相关肽产生、类肉瘤样肉芽肿及疾病超进展相关)及肿瘤溶解综合征相关的低钙和高磷血症。CAR-T治疗相关电解质紊乱以低钠血症为主。早期识别和及时诊断有助于管理这些机制多样的新型电解质紊乱。

要点

  • 免疫检查点抑制剂相关低钠血症以抗利尿不当综合征最常见,内分泌病因罕见。
  • 低钾血症可伴近端和远端肾小管酸中毒。
  • 高钙血症与免疫检查点抑制剂诱导的甲状旁腺激素相关肽产生、类肉瘤样肉芽肿及疾病超进展相关。

核心结论

  • 免疫治疗相关电解质紊乱机制多样,早期识别和及时诊断有助于临床管理。

研究设计与样本

  • 综述,总结免疫检查点抑制剂和嵌合抗原受体T细胞治疗相关的电解质与酸碱紊乱。

主要发现

  • 免疫检查点抑制剂可经多种机制导致低钠血症,抗利尿不当综合征最常见,内分泌病因罕见。
  • 低钾血症并不少见,与近端和远端肾小管酸中毒相关。
  • 免疫检查点抑制剂相关高钙血症与甲状旁腺激素相关肽产生、类肉瘤样肉芽肿及疾病超进展相关。
  • 免疫检查点抑制剂诱导的肿瘤溶解综合征可表现为低钙血症和高磷血症。
  • 嵌合抗原受体T细胞治疗相关电解质紊乱常见,以低钠血症为主,也可出现其他电解质异常。

临床怎么用

  • 早期识别和及时诊断可能有助于提供者管理免疫治疗相关机制多样的新型电解质紊乱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Novel immunotherapy drugs have changed the landscape of cancer medicine. Immune checkpoint inhibitors and chimeric antigen receptor T cells are being used and investigated in almost all types of cancers. Immune-related adverse events have been associated with immunotherapies. AKI has been the most commonly associated kidney adverse event. In this review, we showcase the several associated electrolyte disorders seen with immunotherapy. Immune checkpoint inhibitors can lead to hyponatremia by several mechanisms, with the syndrome of inappropriate antidiuresis being the most common. Endocrine causes of hyponatremia are rare. Hypokalemia is not uncommon and is associated with both proximal and distal renal tubular acidosis. Hypercalcemia associated with immune checkpoint inhibitors has led to some interesting observations, including immune checkpoint inhibitor-induced parathyroid hormone-related peptide production, sarcoid-like granulomas, and hyperprogression of the disease. Hypocalcemia and hyperphosphatemia may be seen with immune checkpoint inhibitor-induced tumor lysis syndrome. Chimeric antigen receptor T cell therapy-associated electrolyte disorders are also common. This is associated chiefly with hyponatremia, although other electrolyte abnormalities can occur. Early recognition and prompt diagnosis may help providers manage the mechanistically varied and novel electrolyte disorders associated with immunotherapy.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Uppal NN, Workeneh BT, Rondon-Berrios H, et al. Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy. Clin J Am Soc Nephrol. 2022. PMID: 35063968. doi:10.2215/CJN.14671121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。